These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Systemic mastocytosis: management of an unusual case with histamine (H1 and H2) antagonists and cyclooxygenase inhibition. Crawhall JC; Wilkinson RD Clin Invest Med; 1987 Jan; 10(1):1-4. PubMed ID: 2880686 [TBL] [Abstract][Full Text] [Related]
3. Greater inhibition of dermographia with a combination of H1 and H2 antagonists. Mansfield LE; Smith JA; Nelson HS Ann Allergy; 1983 Apr; 50(4):264-5. PubMed ID: 6132569 [TBL] [Abstract][Full Text] [Related]
4. Multiple nodular lesions of upper limbs: nodular mastocytosis. Fenniche S; Marrak H; Zghal M; Khayat O; Debbiche A; Ben Ayed M; Mokhtar I Dermatol Online J; 2002 Oct; 8(2):20. PubMed ID: 12546775 [No Abstract] [Full Text] [Related]
5. [Benign systemic mastocytosis: report of 2 cases]. Velloso ED; Beitler B; Chamone DA Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(2):94-8. PubMed ID: 1843375 [TBL] [Abstract][Full Text] [Related]
6. Recurrent syncope and anaphylaxis as presentation of systemic mastocytosis in a pediatric patient: case report and literature review. Shaffer HC; Parsons DJ; Peden DB; Morrell D J Am Acad Dermatol; 2006 May; 54(5 Suppl):S210-3. PubMed ID: 16631942 [TBL] [Abstract][Full Text] [Related]
7. [Bullous mastocytosis in a child]. Haustein UF; Bedri M Hautarzt; 1997 Feb; 48(2):127-9. PubMed ID: 9173060 [TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of systemic mastocytosis with histamine H2 receptor antagonists. Johnson GJ; Silvis SE; Roitman B; Blumenthal M; Gilbert HS Am J Gastroenterol; 1980 Dec; 74(6):485-9. PubMed ID: 6782861 [TBL] [Abstract][Full Text] [Related]
9. [H2-antagonists and possibilities for their therapeutic use in dermatology]. Diller G; Orfanos CE Hautarzt; 1982 Oct; 33(10):521-8. PubMed ID: 6130053 [TBL] [Abstract][Full Text] [Related]
10. [Maculopapular rash, pruritus, upper abdominal pain, attacks of dizziness]. Simon A; Moradpour D; Greminger P Schweiz Rundsch Med Prax; 1991 Nov; 80(48):1357-61. PubMed ID: 1749878 [TBL] [Abstract][Full Text] [Related]
11. Urticaria pigmentosa. Histaminuria and treatment. Tabar AI; Vives R; Valcayo A; Montes M; Varela JI Allergol Immunopathol (Madr); 1990; 18(2):101-3. PubMed ID: 1973586 [TBL] [Abstract][Full Text] [Related]
12. Cutaneous mastocytosis in Thai children. Singalavanija S; Limpongsanurak W J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S143-6. PubMed ID: 19253510 [TBL] [Abstract][Full Text] [Related]
14. Increased production of prostaglandin D2 in patients with systemic mastocytosis. Roberts LJ; Sweetman BJ; Lewis RA; Austen KF; Oates JA N Engl J Med; 1980 Dec; 303(24):1400-4. PubMed ID: 6107852 [No Abstract] [Full Text] [Related]
15. Systemic mastocytosis: current concepts and treatment advances. Tefferi A; Pardanani A Curr Hematol Rep; 2004 May; 3(3):197-202. PubMed ID: 15087068 [TBL] [Abstract][Full Text] [Related]
16. [Cutaneous mastocytosis: A case report]. Zegpi-Trueba MS; Hasbún-Acuña P; Berroeta-Mauriziano D Rev Chil Pediatr; 2016; 87(3):204-7. PubMed ID: 26541705 [TBL] [Abstract][Full Text] [Related]
17. Proconvulsant effect of ketotifen, a histamine H1 antagonist, confirmed by the use of d-chlorpheniramine with monitoring electroencephalography. Yokoyama H; Iinuma K; Yanai K; Watanabe T; Sakurai E; Onodera K Methods Find Exp Clin Pharmacol; 1993 Apr; 15(3):183-8. PubMed ID: 8101246 [TBL] [Abstract][Full Text] [Related]